Skip to content

Acadia Pharmaceuticals ACAD Stock Based Compensation Capitalized

Stock Based Compensation Capitalized at other companies

SolarEdge Technologies logo
SolarEdge TechnologiesSEDG
$762.25K-39.3%
SoundHound AI, Inc. logo
SoundHound AI, Inc.SOUN
$918K
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$173K-18.4%
Navan, Inc.
 logo
Navan, Inc. NAVN
$1.07M+88.4%
CrowdStrike Holdings, Inc. logo
CrowdStrike Holdings, Inc.CRWD
$15.83M+19.1%
Hut 8 Mining Corp. logo
Hut 8 Mining Corp.HUT
$106K

Other financials

Income statement

See full
Revenue$268.1M+9.7%
Gross profit$243.3M+8.6%
Operating income-$4.6M-124%
Net income$3.6M-80.8%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$282.2M+29.6%
Total debt$50.8M-9.3%
Total equity$1.2B+63.1%
Total assets$1.6B+41.8%

Cash flow

See full
Operating cash flow$34.0M+67.2%
CapEx$5.2M
Free cash flow$28.8M+41.6%

Valuation

See full
Market cap$3.87B+37.0%

Profitability

See full
Gross margin91.5%-0.6pp
Operating margin7.4%-16.2pp
Net margin34.3%+11.3pp
FCF margin18.9%

Returns & leverage

See full
Return on equity37.3%+0.1pp
Debt / equity0.0×
Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept acad:StockBasedCompensationCapitalized.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's stock based compensation capitalized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Acadia Pharmaceuticals's stock based compensation capitalized?
Acadia Pharmaceuticals (ACAD) reported stock based compensation capitalized of $118K in Q1 2026.
How has Acadia Pharmaceuticals's stock based compensation capitalized changed year-over-year?
Acadia Pharmaceuticals's stock based compensation capitalized increased by 25.5% year-over-year, from $94K to $118K.
What does stock based compensation capitalized mean?
This represents the portion of stock-based compensation expense that is capitalized into the cost of assets rather than being expensed immediately in the income statement. It reflects the allocation of equity-based rewards to long-term projects or asset development. Understanding this helps investors reconcile total equity compensation with the impact on the balance sheet and future depreciation.